[{"edinetCode":"E01010","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":528.0,"averageTemporaryStaff":194.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11161040.0,"sharesOwendPercent":0.7358,"outstandingShares":null,"numberOfSubsidiary":10.0,"bps":675.21,"equityRatio":0.4722,"cashAndCashEquivalents":3621176000.0,"assets":21317099000.0,"currentAssets":14764278000.0,"fixedAsset":6531472000.0,"tangibleFixedAssets":4662778000.0,"intangibleFixedAssets":621087000.0,"investmentAndOtherAssets":1247607000.0,"liabilities":10837255000.0,"currentLiabilities":9354734000.0,"shorTermDept":575414000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1482521000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":19537000.0,"netAsset":10479844000.0,"capitalStock":9855930000.0,"capital":3050375000.0,"capitalSurplus":2579081000.0,"accumulatedEarnings":4311074000.0,"treasuryStock":-84600000.0,"valuationAndConversionAdjustments":210002000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":26493052000.0,"costOfSales":19287623000.0,"grossProfit":7205428000.0,"sgaExpenses":6481510000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":746526000.0,"operatingIncome":723918000.0,"nonOperatingIncome":149633000.0,"nonOperatingExpenses":267223000.0,"interestExpense":21536000.0,"ordinaryProfit":606328000.0,"extraordinaryGain":45132000.0,"extraordinaryLoss":345466000.0,"incomeBeforeTax":305994000.0,"incomeTaxes":285733000.0,"netIncome":20260000.0,"netIncomeAttributableToOwnersOfTheParentCompany":25387000.0,"comprehensiveIncome":68553000.0,"eps":1.7,"dilutedEps":1.69,"dividendPerShare":null,"per":318.82,"roe":0.0025,"cashFlowFromOperatingActivities":786839000.0,"depreciationAndCashflowFromOperatingActivities":533763000.0,"cashFlowFromInvestingActivities":-671253000.0,"cashFlowFromFinancialActivities":-271847000.0,"changesInCashAndCashEquivalents":-159205000.0,"列1":"asr","submitDate":"2017\/6\/21","stockCode":4999,"accountingYear":"第83期(自　平成28年４月１日　至　平成29年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":535.0,"averageTemporaryStaff":194.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11089140.0,"sharesOwendPercent":0.7424,"outstandingShares":null,"numberOfSubsidiary":9.0,"bps":712.23,"equityRatio":0.4945,"cashAndCashEquivalents":4185213000.0,"assets":21510222000.0,"currentAssets":15648801000.0,"fixedAsset":5781622000.0,"tangibleFixedAssets":4109149000.0,"intangibleFixedAssets":520918000.0,"investmentAndOtherAssets":1151555000.0,"liabilities":10471650000.0,"currentLiabilities":9036630000.0,"shorTermDept":302515000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1435019000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":11038572000.0,"capitalStock":10385998000.0,"capital":3050375000.0,"capitalSurplus":2581581000.0,"accumulatedEarnings":4829557000.0,"treasuryStock":-75515000.0,"valuationAndConversionAdjustments":251679000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":27909949000.0,"costOfSales":20217082000.0,"grossProfit":7692867000.0,"sgaExpenses":6552473000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":840676000.0,"operatingIncome":1140393000.0,"nonOperatingIncome":99737000.0,"nonOperatingExpenses":191653000.0,"interestExpense":6374000.0,"ordinaryProfit":1048477000.0,"extraordinaryGain":127768000.0,"extraordinaryLoss":83270000.0,"incomeBeforeTax":1092976000.0,"incomeTaxes":406581000.0,"netIncome":686394000.0,"netIncomeAttributableToOwnersOfTheParentCompany":667700000.0,"comprehensiveIncome":748059000.0,"eps":44.72,"dilutedEps":44.35,"dividendPerShare":null,"per":20.1,"roe":0.0645,"cashFlowFromOperatingActivities":1305733000.0,"depreciationAndCashflowFromOperatingActivities":521425000.0,"cashFlowFromInvestingActivities":-48388000.0,"cashFlowFromFinancialActivities":-671764000.0,"changesInCashAndCashEquivalents":581825000.0,"列1":"asr","submitDate":"2018\/6\/20","stockCode":4999,"accountingYear":"第84期(自　2017年４月１日　至　2018年３月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":540.0,"averageTemporaryStaff":195.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11171040.0,"sharesOwendPercent":0.7479,"outstandingShares":null,"numberOfSubsidiary":8.0,"bps":758.31,"equityRatio":0.5219,"cashAndCashEquivalents":4199109000.0,"assets":21699978000.0,"currentAssets":16071224000.0,"fixedAsset":5574574000.0,"tangibleFixedAssets":4042060000.0,"intangibleFixedAssets":387061000.0,"investmentAndOtherAssets":1145452000.0,"liabilities":9975174000.0,"currentLiabilities":8524686000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1450488000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":11724804000.0,"capitalStock":11256940000.0,"capital":3050375000.0,"capitalSurplus":2581581000.0,"accumulatedEarnings":5700635000.0,"treasuryStock":-75651000.0,"valuationAndConversionAdjustments":68862000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":27647864000.0,"costOfSales":20285671000.0,"grossProfit":7362193000.0,"sgaExpenses":6071079000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":806239000.0,"operatingIncome":1291113000.0,"nonOperatingIncome":65129000.0,"nonOperatingExpenses":189156000.0,"interestExpense":1593000.0,"ordinaryProfit":1167086000.0,"extraordinaryGain":120465000.0,"extraordinaryLoss":9929000.0,"incomeBeforeTax":1277622000.0,"incomeTaxes":212567000.0,"netIncome":1065054000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1020434000.0,"comprehensiveIncome":872357000.0,"eps":68.32,"dilutedEps":67.72,"dividendPerShare":null,"per":13.66,"roe":0.0929,"cashFlowFromOperatingActivities":793303000.0,"depreciationAndCashflowFromOperatingActivities":539156000.0,"cashFlowFromInvestingActivities":-267114000.0,"cashFlowFromFinancialActivities":-500132000.0,"changesInCashAndCashEquivalents":13896000.0,"列1":"asr","submitDate":"2019\/6\/19","stockCode":4999,"accountingYear":"第85期(自　2018年４月１日　至　2019年３月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5302,"cashAndCashEquivalents":null,"assets":21425900000.0,"currentAssets":15832529000.0,"fixedAsset":5541832000.0,"tangibleFixedAssets":4023933000.0,"intangibleFixedAssets":363526000.0,"investmentAndOtherAssets":1154372000.0,"liabilities":9678074000.0,"currentLiabilities":8288321000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1389753000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":11747825000.0,"capitalStock":11295686000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":5718421000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":65219000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":6487871000.0,"costOfSales":4788425000.0,"grossProfit":1699446000.0,"sgaExpenses":1542283000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":157163000.0,"nonOperatingIncome":19315000.0,"nonOperatingExpenses":43838000.0,"interestExpense":42000.0,"ordinaryProfit":132640000.0,"extraordinaryGain":null,"extraordinaryLoss":737000.0,"incomeBeforeTax":131903000.0,"incomeTaxes":4961000.0,"netIncome":126942000.0,"netIncomeAttributableToOwnersOfTheParentCompany":92464000.0,"comprehensiveIncome":126588000.0,"eps":6.19,"dilutedEps":6.13,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4999,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11185040.0,"sharesOwendPercent":0.7467,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5379,"cashAndCashEquivalents":4451406000.0,"assets":21565957000.0,"currentAssets":15890685000.0,"fixedAsset":5629681000.0,"tangibleFixedAssets":4052688000.0,"intangibleFixedAssets":381593000.0,"investmentAndOtherAssets":1195399000.0,"liabilities":9563379000.0,"currentLiabilities":8180267000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1383111000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12002578000.0,"capitalStock":11516635000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":5939370000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":84091000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":13561053000.0,"costOfSales":9920184000.0,"grossProfit":3640869000.0,"sgaExpenses":3164319000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":412716000.0,"operatingIncome":476550000.0,"nonOperatingIncome":31923000.0,"nonOperatingExpenses":58562000.0,"interestExpense":108000.0,"ordinaryProfit":449911000.0,"extraordinaryGain":null,"extraordinaryLoss":2121000.0,"incomeBeforeTax":447789000.0,"incomeTaxes":85749000.0,"netIncome":362039000.0,"netIncomeAttributableToOwnersOfTheParentCompany":313412000.0,"comprehensiveIncome":377172000.0,"eps":20.95,"dilutedEps":20.78,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":578926000.0,"depreciationAndCashflowFromOperatingActivities":262643000.0,"cashFlowFromInvestingActivities":-234572000.0,"cashFlowFromFinancialActivities":-79816000.0,"changesInCashAndCashEquivalents":252296000.0,"列1":"q2r","submitDate":"2019\/11\/14","stockCode":4999,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5319,"cashAndCashEquivalents":null,"assets":22248239000.0,"currentAssets":16562506000.0,"fixedAsset":5645151000.0,"tangibleFixedAssets":4119912000.0,"intangibleFixedAssets":352389000.0,"investmentAndOtherAssets":1172849000.0,"liabilities":9990473000.0,"currentLiabilities":8605131000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1385341000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12257766000.0,"capitalStock":11709516000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":6132251000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":124045000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":20870312000.0,"costOfSales":15194942000.0,"grossProfit":5675369000.0,"sgaExpenses":4778413000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":896956000.0,"nonOperatingIncome":48957000.0,"nonOperatingExpenses":97848000.0,"interestExpense":136000.0,"ordinaryProfit":848065000.0,"extraordinaryGain":null,"extraordinaryLoss":3997000.0,"incomeBeforeTax":844068000.0,"incomeTaxes":198108000.0,"netIncome":645959000.0,"netIncomeAttributableToOwnersOfTheParentCompany":581191000.0,"comprehensiveIncome":703090000.0,"eps":38.83,"dilutedEps":38.52,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4999,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":555.0,"averageTemporaryStaff":178.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11204540.0,"sharesOwendPercent":0.748,"outstandingShares":null,"numberOfSubsidiary":8.0,"bps":792.85,"equityRatio":0.5309,"cashAndCashEquivalents":4939501000.0,"assets":22371147000.0,"currentAssets":16711584000.0,"fixedAsset":5621036000.0,"tangibleFixedAssets":4191245000.0,"intangibleFixedAssets":332795000.0,"investmentAndOtherAssets":1096995000.0,"liabilities":10045630000.0,"currentLiabilities":8535072000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1510558000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12325516000.0,"capitalStock":11925118000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":6347853000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":-48565000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":27674901000.0,"costOfSales":20118355000.0,"grossProfit":7556546000.0,"sgaExpenses":6332670000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":810854000.0,"operatingIncome":1223875000.0,"nonOperatingIncome":80847000.0,"nonOperatingExpenses":130125000.0,"interestExpense":143000.0,"ordinaryProfit":1174597000.0,"extraordinaryGain":null,"extraordinaryLoss":5326000.0,"incomeBeforeTax":1169271000.0,"incomeTaxes":297493000.0,"netIncome":871777000.0,"netIncomeAttributableToOwnersOfTheParentCompany":796793000.0,"comprehensiveIncome":766672000.0,"eps":53.23,"dilutedEps":52.81,"dividendPerShare":null,"per":11.69,"roe":0.0687,"cashFlowFromOperatingActivities":1585274000.0,"depreciationAndCashflowFromOperatingActivities":543184000.0,"cashFlowFromInvestingActivities":-656890000.0,"cashFlowFromFinancialActivities":-181513000.0,"changesInCashAndCashEquivalents":740391000.0,"列1":"asr","submitDate":"2020\/6\/17","stockCode":4999,"accountingYear":"第86期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5597,"cashAndCashEquivalents":null,"assets":21180402000.0,"currentAssets":15560346000.0,"fixedAsset":5585835000.0,"tangibleFixedAssets":4153571000.0,"intangibleFixedAssets":294547000.0,"investmentAndOtherAssets":1137715000.0,"liabilities":8897168000.0,"currentLiabilities":7400299000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1496868000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12283234000.0,"capitalStock":11907302000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":6330037000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":-52917000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":5647954000.0,"costOfSales":4124520000.0,"grossProfit":1523433000.0,"sgaExpenses":1452561000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":70871000.0,"nonOperatingIncome":32267000.0,"nonOperatingExpenses":23005000.0,"interestExpense":null,"ordinaryProfit":80133000.0,"extraordinaryGain":null,"extraordinaryLoss":997000.0,"incomeBeforeTax":79136000.0,"incomeTaxes":10228000.0,"netIncome":68907000.0,"netIncomeAttributableToOwnersOfTheParentCompany":57082000.0,"comprehensiveIncome":44738000.0,"eps":3.81,"dilutedEps":3.78,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/11","stockCode":4999,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11291540.0,"sharesOwendPercent":0.7538,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.572,"cashAndCashEquivalents":5076749000.0,"assets":21105667000.0,"currentAssets":15511017000.0,"fixedAsset":5564012000.0,"tangibleFixedAssets":4128682000.0,"intangibleFixedAssets":261459000.0,"investmentAndOtherAssets":1173871000.0,"liabilities":8586262000.0,"currentLiabilities":7131699000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1454563000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12519404000.0,"capitalStock":12068759000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":6491494000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":2648000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":11881108000.0,"costOfSales":8664940000.0,"grossProfit":3216167000.0,"sgaExpenses":2910258000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":431593000.0,"operatingIncome":305908000.0,"nonOperatingIncome":33805000.0,"nonOperatingExpenses":45119000.0,"interestExpense":49000.0,"ordinaryProfit":294594000.0,"extraordinaryGain":40930000.0,"extraordinaryLoss":32118000.0,"incomeBeforeTax":303405000.0,"incomeTaxes":69780000.0,"netIncome":233625000.0,"netIncomeAttributableToOwnersOfTheParentCompany":218538000.0,"comprehensiveIncome":276908000.0,"eps":14.59,"dilutedEps":14.47,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":438304000.0,"depreciationAndCashflowFromOperatingActivities":278632000.0,"cashFlowFromInvestingActivities":-213483000.0,"cashFlowFromFinancialActivities":-79731000.0,"changesInCashAndCashEquivalents":137247000.0,"列1":"q2r","submitDate":"2020\/11\/12","stockCode":4999,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5698,"cashAndCashEquivalents":null,"assets":21742506000.0,"currentAssets":16321522000.0,"fixedAsset":5393197000.0,"tangibleFixedAssets":4059971000.0,"intangibleFixedAssets":221401000.0,"investmentAndOtherAssets":1111824000.0,"liabilities":8901809000.0,"currentLiabilities":7445744000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1456064000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12840697000.0,"capitalStock":12387233000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":6809968000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":1430000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":18787395000.0,"costOfSales":13484677000.0,"grossProfit":5302717000.0,"sgaExpenses":4438103000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":864614000.0,"nonOperatingIncome":59441000.0,"nonOperatingExpenses":66694000.0,"interestExpense":49000.0,"ordinaryProfit":857361000.0,"extraordinaryGain":40865000.0,"extraordinaryLoss":34419000.0,"incomeBeforeTax":863807000.0,"incomeTaxes":226994000.0,"netIncome":636812000.0,"netIncomeAttributableToOwnersOfTheParentCompany":611911000.0,"comprehensiveIncome":669099000.0,"eps":40.85,"dilutedEps":40.52,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4999,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":559.0,"averageTemporaryStaff":171.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11340740.0,"sharesOwendPercent":0.7571,"outstandingShares":null,"numberOfSubsidiary":8.0,"bps":868.53,"equityRatio":0.5778,"cashAndCashEquivalents":5865359000.0,"assets":22515923000.0,"currentAssets":16985991000.0,"fixedAsset":5505085000.0,"tangibleFixedAssets":4040864000.0,"intangibleFixedAssets":222138000.0,"investmentAndOtherAssets":1242082000.0,"liabilities":9018378000.0,"currentLiabilities":7630985000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1387393000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13497545000.0,"capitalStock":12838831000.0,"capital":3050375000.0,"capitalSurplus":2588157000.0,"accumulatedEarnings":7261566000.0,"treasuryStock":-61267000.0,"valuationAndConversionAdjustments":171428000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":25759424000.0,"costOfSales":18218159000.0,"grossProfit":7541264000.0,"sgaExpenses":6019120000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":870157000.0,"operatingIncome":1522143000.0,"nonOperatingIncome":84565000.0,"nonOperatingExpenses":88364000.0,"interestExpense":49000.0,"ordinaryProfit":1518345000.0,"extraordinaryGain":42821000.0,"extraordinaryLoss":42287000.0,"incomeBeforeTax":1518879000.0,"incomeTaxes":407141000.0,"netIncome":1111737000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1063509000.0,"comprehensiveIncome":1321947000.0,"eps":71.0,"dilutedEps":70.4,"dividendPerShare":null,"per":10.39,"roe":0.0855,"cashFlowFromOperatingActivities":1431024000.0,"depreciationAndCashflowFromOperatingActivities":536700000.0,"cashFlowFromInvestingActivities":-336453000.0,"cashFlowFromFinancialActivities":-166086000.0,"changesInCashAndCashEquivalents":925858000.0,"列1":"asr","submitDate":"2021\/6\/16","stockCode":4999,"accountingYear":"第87期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5849,"cashAndCashEquivalents":null,"assets":22799884000.0,"currentAssets":17363415000.0,"fixedAsset":5413884000.0,"tangibleFixedAssets":4045731000.0,"intangibleFixedAssets":230785000.0,"investmentAndOtherAssets":1137367000.0,"liabilities":8975435000.0,"currentLiabilities":7580321000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1395114000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13824448000.0,"capitalStock":13145205000.0,"capital":3050375000.0,"capitalSurplus":2598416000.0,"accumulatedEarnings":7548528000.0,"treasuryStock":-52114000.0,"valuationAndConversionAdjustments":191568000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":6893447000.0,"costOfSales":4790859000.0,"grossProfit":2102587000.0,"sgaExpenses":1556056000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":546530000.0,"nonOperatingIncome":27375000.0,"nonOperatingExpenses":22134000.0,"interestExpense":null,"ordinaryProfit":551772000.0,"extraordinaryGain":1598000.0,"extraordinaryLoss":4257000.0,"incomeBeforeTax":549113000.0,"incomeTaxes":170203000.0,"netIncome":378910000.0,"netIncomeAttributableToOwnersOfTheParentCompany":361860000.0,"comprehensiveIncome":416081000.0,"eps":24.15,"dilutedEps":23.93,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/11","stockCode":4999,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11374940.0,"sharesOwendPercent":0.7581,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5912,"cashAndCashEquivalents":6016821000.0,"assets":23331629000.0,"currentAssets":17741595000.0,"fixedAsset":5570911000.0,"tangibleFixedAssets":4066508000.0,"intangibleFixedAssets":231903000.0,"investmentAndOtherAssets":1272500000.0,"liabilities":9043762000.0,"currentLiabilities":7649325000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1394436000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":14287867000.0,"capitalStock":13568390000.0,"capital":3050375000.0,"capitalSurplus":2598416000.0,"accumulatedEarnings":7971746000.0,"treasuryStock":-52147000.0,"valuationAndConversionAdjustments":224800000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":13948703000.0,"costOfSales":9701292000.0,"grossProfit":4247411000.0,"sgaExpenses":3097082000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":451352000.0,"operatingIncome":1150329000.0,"nonOperatingIncome":32477000.0,"nonOperatingExpenses":45628000.0,"interestExpense":23000.0,"ordinaryProfit":1137178000.0,"extraordinaryGain":1553000.0,"extraordinaryLoss":10880000.0,"incomeBeforeTax":1127851000.0,"incomeTaxes":319512000.0,"netIncome":808338000.0,"netIncomeAttributableToOwnersOfTheParentCompany":785077000.0,"comprehensiveIncome":876424000.0,"eps":52.35,"dilutedEps":51.92,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":474279000.0,"depreciationAndCashflowFromOperatingActivities":229701000.0,"cashFlowFromInvestingActivities":-260925000.0,"cashFlowFromFinancialActivities":-93210000.0,"changesInCashAndCashEquivalents":151461000.0,"列1":"q2r","submitDate":"2021\/11\/9","stockCode":4999,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0},{"edinetCode":"E01010","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5866,"cashAndCashEquivalents":null,"assets":24096798000.0,"currentAssets":18557135000.0,"fixedAsset":5524196000.0,"tangibleFixedAssets":4114843000.0,"intangibleFixedAssets":229172000.0,"investmentAndOtherAssets":1180179000.0,"liabilities":9464099000.0,"currentLiabilities":8128166000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1335932000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":14632698000.0,"capitalStock":13950561000.0,"capital":3050375000.0,"capitalSurplus":2598416000.0,"accumulatedEarnings":8353916000.0,"treasuryStock":-52147000.0,"valuationAndConversionAdjustments":184676000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":21301102000.0,"costOfSales":14869599000.0,"grossProfit":6431503000.0,"sgaExpenses":4708468000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1723034000.0,"nonOperatingIncome":65931000.0,"nonOperatingExpenses":69717000.0,"interestExpense":24000.0,"ordinaryProfit":1719248000.0,"extraordinaryGain":1490000.0,"extraordinaryLoss":13015000.0,"incomeBeforeTax":1707723000.0,"incomeTaxes":436663000.0,"netIncome":1271059000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1242285000.0,"comprehensiveIncome":1293185000.0,"eps":82.82,"dilutedEps":82.14,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/8","stockCode":4999,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01010","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3050,"settlementDate":"2022\/3\/31","submitterName":"セメダイン株式会社","submitterNameEnglish":"CEMEDINE CO.,LTD.","submitterNameKana":"セメダインカブシキガイシャ","location":"品川区大崎一丁目１１番２号ゲートシティ大崎イーストタワー","industory":"化学","corporateNumber":1010000000000.0}]